Imagine treating cancer without chemotherapy, radiation, or surgery. For some patients, that possibility is becoming a reality. But it’s also becoming a lucrative business for pharmaceutical giant GSK. The FDA recently granted accelerated approval to dostarlimab, a monoclonal antibody immunotherapy marketed as Jemperli, for patients with rectal cancer. The approval follows years of remarkable research, […]
The post New Non-Chemo Cancer Treatment appeared first on Redacted.
